Doug is a lawyer by training and was called to the Ontario bar in 1999 after a clerkship at the Federal Court of Appeal. His professional experience spans international trade law, intellectual property policy, antitrust law and pharmaceutical pricing and reimbursement. From 2000 to 2023, Doug ascended the executive ranks of the Canadian federal government, including stints as director of patent policy, assistant deputy commissioner of competition, and executive director of the Patented Medicine Prices Review Board (PMPRB). After more than two decades as a public servant, Doug left the federal government to become the first ever CEO of the newly incorporated pan-Canadian Pharmaceutical Alliance (pCPA). Now semi-retired, Doug enjoys an active outdoor lifestyle with his partner, three kids and a very mischevious dog.

Doug brings a wealth of knowledge to his consulting work, born of his many years of senior level experience working on pharmaceutical issues, as well as an abiding enthusiasm for the subject matter. His seasoned insight and expert analysis enables him to provide clients with innovative solutions tailored to the unique challenges of the Canadian pharmaceutical ecosystem. Doug is known for his analytical rigor and ability to communicate complex concepts clearly and effectively. He is passionate about improving the ecosystem as a whole and believes that his clients are best served by solutions that are both practical and holistic.